Conference Reports

Copenhagen
16 March 2018 - 19 March 2018
San Francisco, California
08 February 2018 - 10 February 2018
Hong Kong
20 January 2018 - 20 January 2018
Orlando, Florida
16 February 2017 - 18 February 2017
Singapore
20 July 2016 - 24 July 2016
San Francisco, CA
07 January 2016 - 09 January 2016
Editor's Recommendations
Most Read Articles
01 Aug 2016
Metronomic cyclophosphamide is modestly effective, and may be a safe and non-expensive treatment alternative in hormone-naïve patients with non-metastatic biochemical recurrent prostate cancer, as stated in a prospective single-arm open-label phase II study.